Evaluation of Effectiveness and Safety of NOBORI Stent
NCT01348360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2020-01-30
Summary
The objective of this study is to evaluate effectiveness and safety of Nobori stent in the "real world" daily practice as compared with first-generation drug-eluting stents (sirolimus- or paclitaxel-eluting stents).
Conditions
Sponsors & Collaborators
-
CardioVascular Research Foundation, Korea
collaborator OTHER -
Terumo Corporation
collaborator INDUSTRY -
Seung-Jung Park
lead OTHER
Principal Investigators
-
Seung-Jung Park, MD, PhD · Asan Medical Center
-
Ki Bae Seung, MD, PhD · Seoul St. Mary's Hospital, Catholic University of Korea
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2016-05-31
- Completion
- 2019-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Comparison of Drug Eluting Balloon and Drug Eluting Stent
NCT01539603 ·Status: COMPLETED ·Phase: PHASE2
-
Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions
NCT01186120 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
NCT01350869 ·Status: COMPLETED
-
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
NCT04825886 ·Status: COMPLETED
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV)
NCT01186094 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
NCT01186107 ·Status: COMPLETED ·Phase: PHASE4
-
GENOSS Coronary Stent Clinical Trial
NCT05444452 ·Status: RECRUITING ·Phase: NA
-
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)
NCT01348399 ·Status: COMPLETED
-
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
NCT01826552 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)
NCT01350778 ·Status: COMPLETED
-
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
NCT03967158 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )
NCT01350791 ·Status: COMPLETED
-
Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction
NCT01347554 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
NCT01515228 ·Status: COMPLETED ·Phase: PHASE4
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)
NCT01348022 ·Status: COMPLETED
-
Primary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infarction
NCT04663932 ·Status: UNKNOWN ·Phase: NA
-
Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
NCT02316886 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing
NCT00698607 ·Status: COMPLETED ·Phase: PHASE4
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
NCT01267734 ·Status: UNKNOWN ·Phase: PHASE4
-
The DECISION-CTO Extended 10 Y Follow-up
NCT06908499 ·Status: NOT_YET_RECRUITING
-
NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial
NCT01303640 ·Status: COMPLETED ·Phase: PHASE4
-
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
NCT05066789 ·Status: TERMINATED ·Phase: PHASE4
-
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
NCT00960908 ·Status: UNKNOWN